DelveInsight’s “Non-Hodgkin Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023-7MM” Reports provides an overview of the disease and global market size of the Non-Hodgkin Lymphoma for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the diagnosed cases of Non-Hodgkin Lymphoma from 2012-2023.
Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver.
According to DelveInsight, the market size for Non-Hodgkin Lymphoma of 7 MM is estimated to be USD XX Million by 2023 at a CAGR of 8% for the forecast period i.e., 2012-2023.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Scope
The report will help in developing business strategies by understanding the trends shaping and driving the Non-Hodgkin Lymphoma market.
Organize sales and marketing efforts by identifying the best opportunities for Non-Hodgkin Lymphoma in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
To understand the future market competition in the 7MM market of Non-Hodgkin Lymphoma and Insightful review of the key market drivers and barriers.
To understand the regulatory scenario in major markets.
The Report also covers the detailed historical and forecasted Non-Hodgkin Lymphoma market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2012-2023.
'
Report Introduction
Non-Hodgkin Lymphoma Market Overview at a Glance
Global Market Size of Non-Hodgkin Lymphoma (2012-2023)
7 MM Market Size of Non-Hodgkin Lymphoma (2012-2023)
Total Market Share Distribution of Non-Hodgkin Lymphoma for 7 MM in 2016
Total Market Share Distribution of Non-Hodgkin Lymphoma for 7 MM in 2023
Non-Hodgkin Lymphoma (NHL)
Overview
Types of Non-Hodgkin Lymphoma
Stages of Non-Hodgkin Lymphoma
Pathophysiology
Etiology
Risk Factors
Diagnosis
Treatment
Epidemiology and Patient Population
Total number of cases – 7MM Countries – (2016 & 2023)
United States
Diagnosed Cases of Non-Hodgkin Lymphoma in United States
Germany
Diagnosed Cases of Non-Hodgkin Lymphoma in Germany
France
Diagnosed Cases of Non-Hodgkin Lymphoma in France
United Kingdom
Diagnosed Cases of Non-Hodgkin Lymphoma in United Kingdom
Spain
Diagnosed Cases of Non-Hodgkin Lymphoma in Spain
Italy
Diagnosed Cases of Non-Hodgkin Lymphoma in Italy
Japan
Diagnosed Cases of Non-Hodgkin Lymphoma in Japan
Treatment Algorithm
Current Unmet Needs
Marketed Drugs
Rituxan (MabThera)
Description
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Efficacy
Safety
Side effects
Other marketed Products for Subtypes of NHL
Emerging Therapies
Copanlisib: Bayer AG
Product Development Activities
Clinical Development
Product Profile
Clinical Trial by Phase
Ibrutinib: Janssen Biotech, Inc
Product Development Activities
Clinical Development
Product Profile
Clinical Trial by Phase
Pixantrone: CTI BioPharma Corp.
Product Development Activities
Clinical Development
Product Profile
Clinical Trial by Phase
Other Emerging Therapies for Subtypes of NHL
Global Non-Hodgkin Lymphoma: Country-Wise Market Analysis
Overview on Total Non-Hodgkin Lymphoma Market (2016)
Overview on Total Non-Hodgkin Lymphoma Market (2023)
United States Market Size
Non-Hodgkin Lymphoma (NHL) Distribution Based on Types and Sub Types (2016)
Europe Market Size
Germany Market Size
Non-Hodgkin Lymphoma (NHL) Distribution Based on Types and Sub Types (2016)
France Market Size
Non-Hodgkin Lymphoma (NHL) Distribution Based on Types and Sub Types (2016)
United Kingdom Market Size
Non-Hodgkin Lymphoma (NHL) Distribution Based on Types and Sub Types (2016)
Spain Market Size
Non-Hodgkin Lymphoma (NHL) Distribution Based on Types and Sub Types (2016)
Italy Market Size
Non-Hodgkin Lymphoma (NHL) Distribution Based on Types and Sub Types (2016)
Japan Market Size
Non-Hodgkin Lymphoma (NHL) Distribution Based on Types and Sub Types (2016)
Market Drivers
Market Barriers
Report Methodology
Consulting Services
Disclaimer
About DelveInsight
Table 1: Global Market Size of Non-Hodgkin Lymphoma in USD Million (2012-2023)
Table 2: 7 MM Market Size of Non-Hodgkin Lymphoma in USD Million (2012-2023)
Table 3: Diagnosed Cases Non-Hodgkin Lymphoma in United States (2012-2023)
Table 4: Diagnosed Cases Non-Hodgkin Lymphoma in Germany (2012-2023)
Table 5: Diagnosed Cases Non-Hodgkin Lymphoma in France (2012-2023)
Table 6: Diagnosed Cases Non-Hodgkin Lymphoma in United Kingdom (2012-2023)
Table 7: Diagnosed Cases Non-Hodgkin Lymphoma in Spain (2012-2023)
Table 8: Diagnosed Cases Non-Hodgkin Lymphoma in Italy (2012-2023)
Table 9: Diagnosed Cases Non-Hodgkin Lymphoma in Japan (2012-2023)
Table 10: List of Other Marketed Drugs for Subtypes of NHL
Table 11: Other Emerging therapies for Subtypes of NHL
Table 12: United States Market Size of Non-Hodgkin Lymphoma in USD, Million (2012-2023)
Table 13: Germany Market Size of Non-Hodgkin Lymphoma in USD, Million (2012-2023)
Table 14: France Market Size of Non-Hodgkin Lymphoma in USD, Million (2012-2023)
Table 15: United Kingdom Market Size of Non-Hodgkin Lymphoma in USD, Million (2012-2023)
Table 16: Spain Market Size of Non-Hodgkin Lymphoma in USD, Million (2012-2023)
Table 17: Italy Market Size of Non-Hodgkin Lymphoma in USD, Million (2012-2023)
Table 18: Japan Market Size of Non-Hodgkin Lymphoma in USD, Million (2012-2023)
